Colgate-Palmolive (NYSE:CL) COO Sells $3,311,350.00 in Stock

Colgate-Palmolive Company (NYSE:CL) COO Panagiotis Tsourapas sold 35,000 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares in the company, valued at approximately $985,363.15. The trade was a 77.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Panagiotis Tsourapas also recently made the following trade(s):

• On Thursday, February 12th, Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00.

Colgate-Palmolive Stock Up 0.5%

Shares of CL opened at $96.61 on Monday. The company has a market capitalization of $77.87 billion, a P/E ratio of 36.87, a PEG ratio of 4.36 and a beta of 0.29. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The business’s 50 day simple moving average is $83.80 and its 200-day simple moving average is $81.84. The company has a debt-to-equity ratio of 5.90, a current ratio of 0.42 and a quick ratio of 0.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. As a group, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Institutional Trading of Colgate-Palmolive

A number of institutional investors and hedge funds have recently modified their holdings of the stock. HighPoint Advisor Group LLC increased its stake in Colgate-Palmolive by 0.7% in the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after purchasing an additional 109 shares in the last quarter. Clear Harbor Asset Management LLC increased its position in shares of Colgate-Palmolive by 2.6% in the 4th quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock valued at $356,000 after buying an additional 113 shares in the last quarter. Moneta Group Investment Advisors LLC raised its stake in Colgate-Palmolive by 0.7% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock worth $1,225,000 after buying an additional 114 shares during the period. Sunpointe LLC raised its stake in Colgate-Palmolive by 4.0% during the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after buying an additional 117 shares during the period. Finally, RFG Advisory LLC grew its stake in Colgate-Palmolive by 1.4% in the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after acquiring an additional 123 shares during the period. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

CL has been the topic of several research reports. Raymond James Financial reduced their price objective on Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $93.00 to $97.00 and gave the company an “overweight” rating in a research note on Monday, February 2nd. Argus reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Jefferies Financial Group lifted their price objective on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Finally, UBS Group raised their target price on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.38.

Key Stories Impacting Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Zacks Research raised several forward earnings estimates (including FY2026 to $3.89 and FY2027 to $4.15) and lifted some quarterly targets, signaling better-than-expected longer‑term earnings progression — supportive for valuation upgrades. Zacks estimate revisions (MarketBeat)
• Positive Sentiment: Major brokers have recently raised targets and stance (Morgan Stanley to $100/overweight; JPMorgan to $97/overweight; Wells Fargo nudged its target higher), which can attract buying and help lift the stock. Analyst target changes (MarketBeat)
• Positive Sentiment: Media/TV mention — Jim Cramer highlighted Colgate’s strong growth, a visible endorsement that can spur retail interest and intraday buying. Cramer: Colgate had great growth
• Neutral Sentiment: Dividend and shareholder returns remain intact — Colgate paid the routine $0.52 quarterly dividend (annualized $2.08, ~2.2% yield); supportive for income investors but already priced in for many holders. Dividend announcement (MarketBeat)
• Neutral Sentiment: Institutional activity shows small incremental buys by several funds in Q4 (some managers added to positions), indicating steady institutional ownership (~80% held by institutions). That steady demand can limit downside but isn’t a near-term catalyst. Institutional flows (MarketBeat)
• Negative Sentiment: Significant insider selling: COO Panagiotis Tsourapas sold 15,000 shares (~$1.47M at ~$97.81), reducing his stake materially. Large insider sales can concern investors about timing or personal liquidity needs and may create short‑term selling pressure. COO Panagiotis Tsourapas sells 15,000 shares
• Negative Sentiment: Another insider (John Hazlin) sold ~20,989 shares for ~$1.98M. Multiple insider sales over days amplify the negative signal versus isolated transactions. Investors should watch future filings for patterns. Insider sale: John Hazlin

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.